>
Kernreagenzien für die Erforschung von Infektionskrankheiten
![]() MPXV | ![]() Coronavirus | ![]() Influenza | ![]() RABV | ![]() EBOV | ![]() HIV |
![]() VZV | ![]() ZIKV | ![]() RSV | ![]() NiV | ![]() SFTSV |
>>> SARS-CoV-2 related products:Core reagents for COVID-19 vaccine R&D , Antigens & antibodies for diagnostic kits development , High-throughput solutions for vaccine R&D based on ELISA , Pseudovirus Neutralization Assay Service
>>> Hot Products: Hemagglutinin (HA), Neuraminidase (NA)
>>> Hot Products:Glycoprotein, Anti-RABV glycoprotein antibody
>>> Hot Products: Glycoprotein
>>> Hot Products: gp120
>>> Hot Products: Glycoprotein E
>>> Hot Products: NS1
>>> Hot Products: Glycoprotein G, Fusion glycoprotein F0 (Pre-fusion, Post-fusion)
>>> Hot Products: Glycoprotein, Fusion glycoprotein
>>> Hot Products:Gn protein
HEK293-Expression: Die Proteinstruktur ist näher an der natürlichen Konformation;
Hohe Reinheit bestätigt durch SDS-PAGE und MALS;
Hohe Bioaktivität, nachgewiesen durch Antigen-Antikörper- oder Antigen-Rezeptor-Bindungsversuche;
Hohe Immunogenität, die zu höheren Antikörpertitern führen kann;
Es kann für das Screening von Medikamenten und die Entwicklung von Impfstoffen verwendet werden.
The purity of HRSV (A) Fusion glycoprotein F0, His Tag (Cat. No. RSF-V52H6) is more than 95% verified by SDS-PAGE and 90% and verified by SEC-MALS. The molecular weight of this protein is around 148-182kDa.
Immobilized HRSV (A) Fusion glycoprotein F0, His Tag (Cat. No. RSF-V52H7) at 2 μg/mL (100 μL/well) can bind Anti-Fusion glycoprotein F0 Antibody, Human IgG1 (D25) with a linear range of 0.2-1 ng/mL (QC tested).
Immobilized HRSV (A) Fusion glycoprotein F0, His Tag (Cat. No. RSF-V52H7) at 2 μg/mL (100 μL/well) can bind Anti-Fusion glycoprotein F0 Antibody, Mouse IgG2a (101F) with a linear range of 0.2-5 ng/mL (Routinely tested).
Loaded Monoclonal Anti-SARS-CoV-2 Spike RBD Antibody, Mouse IgG1 (Cat. No. SPD-M305) on AMC Biosensor, can bind SARS-CoV-2 Spike RBD, His Tag (B.1.1.529/Omicron) (Cat. No. SPD-C522e) with an affinity constant of 9.07 nM as determined in BLI assay (ForteBio Octet Red96e).
Post-vaccination serum samples are tested with Anti-SARS-CoV-2 Antibody IgG Titer Serologic Assay Kit (Spike RBD) (Cat. No.RAS-T024), which accurately and precisely measure antibody titer in serum (Accuracy≤±15%; Intra-assay precision<10%; Inter-assay precision <15%).
SARS-CoV-2 Spike (WT) Fluc-GFP Pseudovirus (Cat. No. PSSW-HLGB001) and SARS-CoV-2 Spike (Omicron) Fluc-GFP Pseudovirus (Cat. No. PSSO-HLGB003) can be neutralized by Anti-SARS-CoV-2 Spike RBD Neutralizing Antibody (Cat. No. SPD-M265, S1N-M122) with inhibition rates of more than 99%. The antibody, REGN10987, which has been reported that Omicron mutant strain can escape, can effectively neutralize SARS-CoV-2 Spike (WT) Fluc-GFP Pseudovirus (Cat. No. PSSW-HLGB001) but not SARS-CoV-2 Spike (Omicron) Fluc-GFP Pseudovirus (Cat. No. PSSO-HLGB003).
SARS-CoV-2 Spike (Omicron) Fluc-GFP Pseudovirus (Cat. No. PSSO-HLGB003) can be neutralized by serum from immunized mice. The inhibition rates come up to more than 99%.
This web search service is supported by Google Inc.